OR WAIT 15 SECS
July 18, 2016
Bach Pharma Inc. (North Andover, MA) has appointed Kelly Blackburn as Chief Executive Officer.
Ms. Blackburn was previously Vice President of Clinical Affairs at aTyr Pharma (San Diego, CA). Prior to that she was at Vertex Pharmaceuticals.
Ms. Blackburn is tasked with leading Bach Pharma as it brings its lead candidate, GVT, into the clinic.
The company also announced that Mark O. Henry will serve as Chief Financial Officer, transitioning from his role as CEO.